Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-01-01 @ 12:13 PM
Study NCT ID:
NCT01249066
Status:
UNKNOWN
Last Update Posted:
2010-11-29
First Post:
2010-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Sponsor:
China Medical University Hospital
Organization:
Study Overview
Official Title:
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Status:
UNKNOWN
Status Verified Date:
2010-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: